Endre søk
Begrens søket
1 - 25 of 25
RefereraExporteraLink til resultatlisten
Permanent link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Treff pr side
  • 5
  • 10
  • 20
  • 50
  • 100
  • 250
Sortering
  • Standard (Relevans)
  • Forfatter A-Ø
  • Forfatter Ø-A
  • Tittel A-Ø
  • Tittel Ø-A
  • Type publikasjon A-Ø
  • Type publikasjon Ø-A
  • Eldste først
  • Nyeste først
  • Skapad (Eldste først)
  • Skapad (Nyeste først)
  • Senast uppdaterad (Eldste først)
  • Senast uppdaterad (Nyeste først)
  • Disputationsdatum (tidligste først)
  • Disputationsdatum (siste først)
  • Standard (Relevans)
  • Forfatter A-Ø
  • Forfatter Ø-A
  • Tittel A-Ø
  • Tittel Ø-A
  • Type publikasjon A-Ø
  • Type publikasjon Ø-A
  • Eldste først
  • Nyeste først
  • Skapad (Eldste først)
  • Skapad (Nyeste først)
  • Senast uppdaterad (Eldste først)
  • Senast uppdaterad (Nyeste først)
  • Disputationsdatum (tidligste først)
  • Disputationsdatum (siste først)
Merk
Maxantalet träffar du kan exportera från sökgränssnittet är 250. Vid större uttag använd dig av utsökningar.
  • 1.
    Beckman, Linda
    et al.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Janson, Staffan
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    von Kobyletzki, Laura B.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013). Lund Univ, Skne Univ Hosp, Dept Dermatol, Inst Clin Res Malmo, Malmo, Sweden.;Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Associations between neurodevelopmental disorders and factors related to school, health, and social interaction in schoolchildren: Results from a Swedish population-based survey2016Inngår i: Disability and Health Journal, ISSN 1936-6574, E-ISSN 1876-7583, Vol. 9, nr 4, s. 663-672Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Background: Children and adolescents with autism spectrum disorder (ASD) or attention-deficit/hyperactivity disorder (ADHD) are more likely to be surrounded by different risk factors. In order to work preventively with decreasing ADHD and ASD symptoms, there is a need of more knowledge concerning risk factors. Objective: This study aimed to investigate school, health, lifestyle and social interactions association with autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) among schoolchildren aged 6-17 years. Methods: Data for 18,416 children and adolescents aged 6-17 years in the county of Varmland, Sweden, from the school year 2012/2013 and 2013/2014 were obtained from the Student Health Database, which includes information on health examinations by school nurses and self-reported information of mental and physical health, social relations, physical activity, and school conditions. Results: Of all participants, 2.4% reported only ADHD and 1.6% reported only ASD. The results confirmed that ADHD or ASD was significantly associated with worse school experiences, lower socioeconomic status, less physical activity, more substance use, weaker social network and more impairments than those without ADHD or ASD. Conclusions: Knowledge of risk or protective factors during school years is needed to develop interventions to reduce symptoms of neurodevelopmental disorders in children and adolescents.

  • 2.
    Beckman, Linda
    et al.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Janson, Staffan
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013). Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
    von Kobyletzki, Laura B.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013). Lund University, Skåne University Hospital, Department of Dermatology, Malmö, Sweden.
    Corrigendum to “Associations between neurodevelopmental disorders and factors related to school, health, and social interaction in schoolchildren Results from a Swedish population-based survey” [Disabil Health J 9(4) (2016) 663–672](S1936657416300723)(10.1016/j.dhjo.2016.05.002)2018Annet (Fagfellevurdert)
    Abstract [en]

    In the article ‘‘Associations between neurodevelopmental disorders and factors related to school, health, and social interaction in schoolchildren: Results from a Swedish population-based survey’’ Disability and Health Journal 2016; 9(4):663–672 by Linda Beckman, Staffan Janson, and Laura von Kobyletzki on page 2 the ethical considerations under section “Questionnaires, interviews, and health examinations”, the following sentence “The ELSA project has been approved by the regional ethical research committee in Uppsala, Sweden (reg. no: 2013/160).”should read as “The study has been reviewed by the local ethical research committee in Karlstad, Sweden (reg. no: C2015/65).”

  • 3.
    Beckman, Linda
    et al.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    von Kobyletzki, Laura B.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Economic Costs of Antidepressant Use: A Population-Based Study in Sweden.2019Inngår i: Journal of Mental Health Policy and Economics, ISSN 1091-4358, E-ISSN 1099-176XArtikkel i tidsskrift (Fagfellevurdert)
  • 4.
    Beckman, Linda
    et al.
    Karlstads universitet, Fakulteten för humaniora och samhällsvetenskap (from 2013), Centrum för forskning om barns och ungdomars psykiska hälsa (from 2013). Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013). Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för miljö- och livsvetenskaper (from 2013). Karlstad Univ, Dept Publ Hlth, Univ Gatan 2, S-65188 Karlstad, Sweden..
    von Kobyletzki, Laura B.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013). Karlstad Univ, Dept Publ Hlth, Univ Gatan 2, S-65188 Karlstad, Sweden.;Lund Univ, Skane Univ Hosp, Dept Dermatol, Jan Waldenstroms Gatan 16, S-21428 Malmo, Sweden..
    Svensson, Mikael
    Sahlgrenska Univ, Hlth Metr Unit, Box 414, S-40530 Gothenburg, Sweden..
    Determinants of Antidepressants Use and Economic Costs: A Population Based Study2017Inngår i: Journal of Mental Health Policy and Economics, Vol. 20, nr Suppl.1, s. S2-S2Artikkel i tidsskrift (Annet vitenskapelig)
  • 5.
    Boman Lindström, Cecilia
    et al.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    von Kobyletzki, Laura
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Hallerbäck, M.U.
    Central Hospital Karlstad.
    Lindh, C.H.
    Lund University.
    Jönsson, B.A.
    Lund University.
    Knutz, Malin
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Shu, Huan
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Bornehag, Carl-Gustaf
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Perfluorinated compounds in serum from 2, 373 pregnant women in Sweden2014Inngår i: Indoor Air, ISSN 0905-6947, E-ISSN 1600-0668, s. 927-929Artikkel i tidsskrift (Fagfellevurdert)
  • 6.
    Chalmers, J. R.
    et al.
    Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham, England..
    Simpson, E.
    Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA..
    Apfelbacher, C. J.
    Univ Regensburg, Inst Epidemiol & Prevent Med, Med Sociol, D-93053 Regensburg, Germany..
    Thomas, K. S.
    Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham, England..
    von Kobyletzki, Laura B.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013). Lund Univ, Skane Univ Hospital, Dept Dermatol, Malmo, Sweden.
    Schmitt, J.
    Univ Dresden, Ctr Lvidence Based Hlthcare, Dresden, Germany.;Tech Univ Dresden, Dept Occupat & Social Med, D-01062 Dresden, Germany..
    Singh, J. A.
    Birmingham VA Med Ctr, Med Serv, Birmingham, AL USA.;Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA..
    Svensson, A.
    Malmo Univ Hosp, Dept Dermatol & Venerol, Malmo, Sweden..
    Williams, H. C.
    Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham, England..
    Abuabara, K.
    Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA..
    Aoki, V.
    Univ Sao Paulo, Sch Med, Dept Dermatol, Sao Paulo, Brazil..
    Ardeleanu, M.
    Regeneron Pharmaceut Inc, Immunol & Inflammat, New York, NY USA..
    Awici-Rasmussen, M.
    Psoriasis & Eczema Assoc Norway, Oslo, Norway..
    Barbarot, S.
    CHU Nantes, Dept Dermatol, F-44035 Nantes 01, France..
    Berents, T. L.
    Univ Oslo, Inst Clin Med, Oslo 3, Norway.;Oslo Univ Hosp, Dept Dermatol, Oslo, Norway..
    Block, J.
    Natl Eczema Assoc, Natl Eczema Org, San Rafael, CA USA..
    Bragg, A.
    Chugai Pharma Europe Ltd, London, England..
    Burton, T.
    Clemmensen, K. K. Bjerring
    Univ Copenhagen, Bispebjerg Hosp, Dept Dermatol, Copenhagen, Denmark..
    Creswell-Melville, A.
    Soc Canadienne IEczema, Keswick, ON, Canada..
    Dinesen, M.
    LEO Pharma AS, Industriparken 55, Ballerup, Denmark..
    Drucker, A.
    Univ Hlth Nem ork, Div Dermatol, Toronto, ON, Canada..
    Eckert, L.
    Hlth Econ & Outcomes Res, Sanofi, France..
    Flohr, C.
    Guys & St Thomas Hosp NHS Fdn Trust, St Johns Inst Dermatol, London, England.;Kings Coll London, London, England..
    Garg, M.
    LEO Pharma, Copenhagen, Denmark..
    Gerbens, L. A. A.
    Univ Amsterdam, Acad Med Ctr, Dept Dermatol, Amsterdam, Netherlands..
    Graff, A. L. B.
    Natl Eczema Soc, London, England..
    Hanifin, J.
    Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA..
    Heinl, D.
    Univ Regensburg, Inst Epidemiol & Prevent Med, Med Sociol, D-93053 Regensburg, Germany..
    Humphreys, R.
    Natl Eczema Soc, London, England..
    Ishii, H. A.
    Brazilian Atop Dermatitis Assoc AADA, Sao Paulo, Brazil..
    Kataoka, Y.
    Osaka Prefectural Med Ctr Resp & Allerg Dis, Osaka, Japan..
    Leshem, Y. A.
    Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA..
    Marquort, B.
    Massuel, M. -A
    Merhand, S.
    Assoc Francaise Eczema, Redon, France..
    Mizutani, H.
    Mie Univ, Grad Sch Med, Tsu, Mie, Japan.;Mie Univ, Hosp Tsu, Tsu, Mie, Japan..
    Murota, H.
    Osaka Univ, Dept Dermatol, Osaka, Japan..
    Murrell, D. F.
    St George Hosp, Dept Dermatol, Sydney, NSW, Australia.;Univ New S Wales, Sydney, NSW, Australia..
    Nakahara, T.
    Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka, Japan..
    Nasr, I.
    Nograles, K.
    Greater New York City Area Pharmaceut, Celgene Corp, New York, NY USA..
    Ohya, Y.
    Natl Ctr Child Hlth & Dev, Dept Med Subspecialties, Div Allergy, Tokyo, Japan..
    Osterloh, I.
    Ostermed Ltd, Kent, OH USA..
    Pander, J.
    Celgene BV, Utrecht, Netherlands..
    Prinsen, C.
    Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands..
    Purkins, L.
    Ziarco Pharma Ltd, Canterbury, Kent, England..
    Ridd, M.
    Univ Bristol, Sch Social & Community Med, Bristol, Avon, England..
    Sach, T.
    Univ E Anglia, Hlth Econ Grp, Norwich, Norfolk, England..
    Schuttelaar, M. -LA.
    Shindo, S.
    Osaka Univ, Dept Dermatol, Osaka, Japan..
    Smirnova, J.
    Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Sulzer, A.
    Sanofi Aventis, Montpellier, France..
    Gjerde, E. Synnove
    Psoriasis & Eczema Assoc Norway, Oslo, Norway..
    Takaoka, R.
    Univ Sao Paulo, Sch Med, Dept Dermatol, Sao Paulo, Brazil..
    Talmo, H. Vestby
    Sanofi Aventis, Montpellier, France..
    Tauber, M.
    Toulouse Univ, Toulouse, France..
    Torchet, F.
    Mie Univ, Grad Sch Med, Tsu, Mie, Japan.;Mie Univ, Hosp Tsu, Tsu, Mie, Japan..
    Volke, A.
    Univ Tartu, Dept Dermatol, Tartu, Estonia..
    Wahlgren, C. -F
    Weidinger, S.
    Venereol & Allergy Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany..
    Weisshaar, E.
    Heidelberg Univ, Dept Social Med, Occupat & Environm Dermatol, Heidelberg, Germany..
    Wollenberg, A.
    Univ Munich, Dept Dermatol & Allergy, Munich, Germany..
    Yamaga, K.
    Osaka Univ, Dept Dermatol, Osaka, Japan..
    Zhao, C. Y.
    St George Hosp, Dept Dermatol, Sydney, NSW, Australia.;Univ New S Wales, Sydney, NSW, Australia..
    Spuls, P. I.
    Univ Amsterdam, Acad Med Ctr, Dept Dermatol, Amsterdam, Netherlands..
    Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)2016Inngår i: British Journal of Dermatology, ISSN 0007-0963, E-ISSN 1365-2133, Vol. 175, nr 1, s. 69-79Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    This article is a report of the fourth meeting of the Harmonising Outcome Measures for Eczema (HOME) initiative held in Malmo, Sweden on 23-24 April 2015 (HOME IV). The aim of the meeting was to achieve consensus over the preferred outcome instruments for measuring patient-reported symptoms and quality of life for the HOME core outcome set for atopic eczema (AE). Following presentations, which included data from systematic reviews, consensus discussions were held in a mixture of whole group and small group discussions. Small groups were allocated a priori to ensure representation of different stakeholders and countries. Decisions were voted on using electronic keypads. For the patient-reported symptoms, the group agreed by vote that itch, sleep loss, dryness, redness/inflamed skin and irritated skin were all considered essential aspects of AE symptoms. Many instruments for capturing patient-reported symptoms were discussed [ including the Patient-Oriented SCOring Atopic Dermatitis index, Patient-Oriented Eczema Measure (POEM), Self-Administered Eczema Area and Severity Index, Itch Severity Scale, Atopic Dermatitis Quickscore and the Nottingham Eczema Severity Score] and, by consensus, POEM was selected as the preferred instrument to measure patient-reported symptoms. Further work is needed to determine the reliability and measurement error of POEM. Further work is also required to establish the importance of pain/soreness and the importance of collecting information regarding the intensity of symptoms in addition to their frequency. Much of the discussion on quality of life concerned the Dermatology Life Quality Index and Quality of Life Index for Atopic Dermatitis; however, consensus on a preferred instrument for measuring this domain could not be reached. In summary, POEM is recommended as the HOME core outcome instrument for measuring AE symptoms.

  • 7. Chalmers, J. R.
    et al.
    Thomas, K. S.
    Apfelbacher, C.
    Williams, H. C.
    Prinsen, C. A.
    Spuls, P. I.
    Simpson, E.
    Gerbens, L. A. A.
    Boers, M.
    Barbarot, S.
    Stalder, J. F.
    Abuabara, K.
    Aoki, V.
    Ardeleanu, M.
    Armstrong, J.
    Bang, B.
    Berents, T. L.
    Burton, T.
    Butler, L.
    Chubachi, T.
    Cresswell-Melville, A.
    DeLozier, A.
    Eckert, L.
    Eichenfield, L.
    Flohr, C.
    Futamura, M.
    Gadkari, A.
    Gjerde, E. S.
    van Halewijn, K. F.
    Hawkes, C.
    Howells, L.
    Howie, L.
    Humphreys, R.
    Ishii, H. A.
    Kataoka, Y.
    Katayama, I.
    Kouwenhoven, W.
    Langan, S. M.
    Leshem, Y. A.
    Merhand, S.
    Mina-Osorio, P.
    Murota, H.
    Nakahara, T.
    Nunes, F. P.
    Nygaard, U.
    Nygardas, M.
    Ohya, Y.
    Ono, E.
    Rehbinder, E.
    Rogers, N. K.
    Romeijn, G. L. E.
    Schuttelaar, M. L. A.
    Sears, A. V.
    Simpson, M. A.
    Singh, J. A.
    Srour, J.
    Stuart, B.
    Svensson, A.
    Talmo, G.
    Talmo, H.
    Teixeira, H. D.
    Thyssen, J. P.
    Todd, G.
    Torchet, F.
    Volke, A.
    von Kobyletzki, Laura B.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013). Karolinska Institutet; Lund University; University Hospital Schleswig-Holstein, Kiel, Germany.
    Weisshaar, E.
    Wollenberg, A.
    Zaniboni, M.
    Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)2018Inngår i: British Journal of Dermatology, ISSN 0007-0963, E-ISSN 1365-2133, Vol. 178, nr 5, s. E332-E341Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    This is the report from the fifth meeting of the Harmonising Outcome Measures for Eczema initiative (HOME V). The meeting was held on 12-14 June 2017 in Nantes, France, with 81 participants. The main aims of the meeting were (i) to achieve consensus over the definition of the core domain of long-term control and how to measure it and (ii) to prioritize future areas of research for the measurement of the core domain of quality of life (QoL) in children. Moderated whole-group and small-group consensus discussions were informed by presentations of qualitative studies, systematic reviews and validation studies. Small-group allocations were performed a priori to ensure that each group included different stakeholders from a variety of geographical regions. Anonymous whole-group voting was carried out using handheld electronic voting pads according to pre-defined consensus rules. It was agreed by consensus that the long-term control domain should include signs, symptoms, quality of life and a patient global instrument. The group agreed that itch intensity should be measured when assessing long-term control of eczema in addition to the frequency of itch captured by the symptoms domain. There was no recommendation of an instrument for the core outcome domain of quality of life in children, but existing instruments were assessed for face validity and feasibility, and future work that will facilitate the recommendation of an instrument was agreed upon.

  • 8.
    Holzgraefe, Bernhard
    et al.
    Karolinska institutet.
    Larsson, Anders
    Uppsala universitet.
    von Kobyletzki, Laura B.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Do we have scientific evidence about the effect of hypoxaemia on cognitive outcome in adult patients with severe acute respiratory failure?2018Inngår i: Upsala Journal of Medical Sciences, ISSN 0300-9734, E-ISSN 2000-1967, Vol. 123, nr 1, s. 68-70Artikkel i tidsskrift (Fagfellevurdert)
  • 9.
    Howells, L.
    et al.
    Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham, England.
    von Kobyletzki, Laura B.
    Lunds universitet.
    Beckman, Linda
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Defining and measuring 'eczema control': an international qualitative study to explore the views of those living with and treating atopic eczema2019Inngår i: Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, E-ISSN 1468-3083, Vol. 33, nr 6, s. 1124-1132Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Background Atopic eczema (also known as eczema) is a chronic, inflammatory skin condition that often afflicts patients' health and well-being. The Harmonising Outcome Measures for Eczema (HOME) initiative recommends that 'long-term control of eczema' is measured in all clinical trials 3 months or longer in duration. However, little has been published on what eczema control means to those living with or treating atopic eczema. Objectives To (i) develop understanding of what eczema control means to patients, carers and clinicians and (ii) explore the feasibility and acceptability of different ways of measuring eczema control in the long term. Methods Online focus groups explored patients/carers experiences in the UK, the United States, the Netherlands, France, Sweden and Japan, and an international online survey gathered views of clinicians. The framework method was used to analyse the focus groups, and thematic analysis was used to analyse survey data. All findings were integrated into a theoretical framework to create overarching themes that cut across these diverse groups. Results Eight focus groups with patients (16 years+) and eight groups with carers of children took place (N = 97). Sixty-two people took part in the survey. Eczema control was described as a multifaceted construct involving changes in disease activity, the treatment and management of the condition and psychological, social and physical functioning. Patient/carer measurement allows personal accounts and frequent measurement, whilst clinician measurement was deemed less subjective. The burden on patients/carers and issues for analysing and interpreting data should be considered. Conclusions This study formed the basis of judging the content validity and feasibility of measurement instruments/methods to assess control of eczema in clinical trials. This online approach to an international qualitative study is an example of how core outcome set developers with limited resources can engage with multiple stakeholder groups on an international basis to inform consensus meeting discussions.

  • 10.
    Kobyletzki, Laura
    et al.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper. Lund University.
    Brockmeyer, N. H.
    Germany.
    Potthoff, A.
    Germany.
    Svensson, A.
    Lund University.
    Johnsson, A.
    Lund University.
    Multiple penile ulcers revealing syphilis, lymphogranuloma venereum and primary HIV infection in man who have sex with men2012Inngår i: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, E-ISSN 1610-0387, Vol. 10, s. 40-41Artikkel i tidsskrift (Fagfellevurdert)
  • 11.
    Mischo, Meike
    et al.
    Ruhr Univ Bochum, Bochum, Germany..
    von Kobyletzki, Laura B
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper. Lund Univ, Skne Univ Hosp, Dept Dermatol, Inst Clin Res Malmo, Malmo, Sweden.;Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Bruendermann, Erik
    Ruhr Univ Bochum, Bochum, Germany..
    Schmidt, Diedrich A.
    Ruhr Univ Bochum, Bochum, Germany..
    Potthoff, Anja
    Ruhr Univ Bochum, Dept Dermatol, Bochum, Germany..
    Brockmeyer, Norbert H.
    Ruhr Univ Bochum, Dept Dermatol, Bochum, Germany.;Ruhr Univ Bochum, Competence Network HIV Aids, Bochum, Germany..
    Havenith, Martina
    Ruhr Univ Bochum, Bochum, Germany..
    Similar appearance, different mechanisms: xerosis in HIV, atopic dermatitis and ageing2014Inngår i: Experimental dermatology, ISSN 0906-6705, E-ISSN 1600-0625, Vol. 23, nr 6, s. 446-448Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Xerosis is one of the most common dermatologic disorders occurring in the elderly and in patients with atopic dermatitis (AD) and human immunodeficiency virus (HIV) infection. Xerosis has been linked to an impaired skin barrier function of the stratum corneum. Using Raman microspectroscopy, we concentrated on deeper skin layers, viable epidermis and dermis of 47 volunteers and associated molecular alterations to the evolution of xerosis and the skin barrier, for example, lipid, water and antioxidant content. A decrease in lipids within the viable epidermis is found for elderly and HIV-patients. Lipid and water values of AD patients and their healthy reference group are similar. Decreases in lipids and simultaneous increases in water are found in the dermis for HIV and AD patients in comparison to their healthy reference groups. Excessive levels of epidermal carotenoids, mainly lycopene, in HIV-patients were found potentially leading to adverse effects such as premature skin ageing.

  • 12.
    Schmitt, J.
    et al.
    Tech Univ Dresden, Ctr Evidence Based Healthcare, D-01062 Dresden, Germany..
    Langan, S.
    London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England..
    Deckert, S.
    Tech Univ Dresden, Ctr Evidence Based Healthcare, D-01062 Dresden, Germany..
    Svensson, A.
    Lund Univ, Inst Clin Sci, Dept Dermatol, Malmo, Sweden..
    von Kobyletzki, Laura B
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper. Lund Univ, Skne Univ Hosp, Dept Dermatol, Inst Clin Res Malmo, Malmo, Sweden.;Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Thomas, K. S.
    Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2RD, England..
    Spuls, P.
    Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands..
    How to measure clinical signs of atopic dermatitis?: A systematic review and recommendation2014Inngår i: British Journal of Dermatology, ISSN 0007-0963, E-ISSN 1365-2133, Vol. 170, nr 6, s. E40-E41Artikkel i tidsskrift (Annet vitenskapelig)
  • 13.
    Schmitt, Jochen
    et al.
    Germany.
    Langan, Sinéad
    Germany.
    Deckert, Stefanie
    Germany.
    Svensson, Ake
    Germany.
    von Kobyletzki, Laura
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper.
    Thomas, Kim
    Germany.
    Spuls, Phyllis
    Germany.
    Assessment of clinical signs of atopic dermatitis: A systematic review and recommendation2013Inngår i: Journal of Allergy and Clinical Immunology, ISSN 0091-6749, E-ISSN 1097-6825, Vol. 132, nr 6Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    BACKGROUND: Clinical signs are a core outcome domain for atopic dermatitis (AD) trials. The current lack of standardization of outcome measures in AD trials hampers evidence-based communication.

    OBJECTIVE: We sought to provide evidence-based recommendations for the measurement of clinical signs in AD trials and to inform the Harmonising Outcome Measures for Atopic Dermatitis Initiative.

    METHODS: We conducted a systematic review on measurement properties of outcome measurements for clinical signs of AD. We systematically searched MEDLINE and Embase (until October 1, 2012) for validation studies on instruments measuring the clinical signs of AD. Grading of the truth, discrimination, and feasibility of scales; methodological study quality; and recommendations were based on predefined criteria.

    RESULTS: Sixteen eligible instruments were identified, of which 2 were best validated. The Eczema Area and Severity Index has adequate validity, responsiveness, internal consistency, intraobserver reliability, and intermediate interobserver reliability but unclear interpretability and feasibility. The Severity Scoring of Atopic Dermatitis Index (SCORAD) has adequate validity, responsiveness, interobserver reliability, and interpretability and unclear intraobserver reliability. Only the objective SCORAD (ie, the clinical signs domain of the SCORAD) is internally consistent. The Six Area, Six Sign Atopic Dermatitis Index severity score and Three Item Severity Score fulfill some quality criteria, but the performance in other required measurement properties is unclear. The Patient-oriented Eczema Measure is reliable and responsive but has inadequate content validity to assess clinical signs of AD. The remaining 11 scales have either (almost) not been validated or performed inadequately.

    CONCLUSIONS: The Eczema Area and Severity Index and SCORAD are the best instruments to assess the clinical signs of AD. The other 14 instruments identified are (currently) not recommended because of unclear or inadequate measurement properties.

  • 14.
    von Kobyletzki, Laura B.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013). Lund Univ, Skne Univ Hosp, Dept Dermatol, Inst Clin Res Malmo, Malmo, Sweden.;Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Atopic eczema and nonatopic eczema show the same pattern in an adolescent general population2015Inngår i: British Journal of Dermatology, ISSN 0007-0963, E-ISSN 1365-2133, Vol. 173, nr 4, s. 889-889Artikkel i tidsskrift (Fagfellevurdert)
  • 15.
    von Kobyletzki, Laura B.
    et al.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013). Lunds universitet.
    Beckman, Linda
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Smeeth, Liam
    London Sch Hyg & Trop Med, London, England.
    McKee, Martin
    London Sch Hyg & Trop Med, London, England; .
    Quint, Jennifer K.
    Imperial Coll London, Resp Epidemiol Occupat Med & Publ Hlth, London.
    Abuabara, Katrina
    Univ Calif San Francisco, Dept Dermatol, Program Clin Res, San Francisco.
    Langan, Sinead
    London Sch Hyg & Trop Med, London, England; St Johns Inst Dermatol, Dept Dermatol, London, England.
    Association between childhood allergic diseases, educational attainment and occupational status in later life: systematic review protocol2017Inngår i: BMJ Open, ISSN 2044-6055, E-ISSN 2044-6055, Vol. 7, nr 10, artikkel-id e017245Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Introduction Childhood allergic diseases may prevent affected children from achieving their academic potential. Potential mechanisms include absence from school due to illness and medical appointments. Experience of symptoms in classes or leisure time, and stigma associated with visible signs and symptoms, including skin disease, requirements for medication during school time or the need for specific diets, may also contribute to reduced educational attainment. Studies have investigated the association between specific allergic diseases and educational attainment. The aim of this study is to systematically review the literature on allergic diseases, educational attainment and occupational status, and if possible, calculate meta-analytic summary estimates for the associations. Methods Systematic electronic searches in Medline, EMBASE, Cochrane, Cumulative Index to Nursing & Allied Health Literature (CINAHL), PsycINFO and education Resources Information Center (ERIC); hand search in reference lists of included papers and conference reports; search for unpublished studies in clinical trial registers and the New York Academy of Medicine Grey Literature Report; data extraction; and study quality assessment (Newcastle-Ottawa Scale) will be performed. Analysis Data will be summarised descriptively, and meta-analysis including meta-regression to explore sources of heterogeneities will be performed if possible. Ethics and dissemination Dissemination in a peer-reviewed, open-access, international scientific journal is planned.

  • 16.
    von Kobyletzki, Laura B.
    et al.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013). Lund Univ, Skne Univ Hosp, Dept Dermatol, Inst Clin Res Malmo, Malmo, Sweden.;Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Beckman, Linda
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Smirnova, J
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Smeeth, L
    London School of Hygiene and Tropical Medicine.
    Williams, H C
    Centre of Evidence Based Dermatology, University of Nottingham.
    McKee, M
    London School of Hygiene and Tropical Medicine.
    Abuabara, K
    University of California, San Francisco, USA.
    Langan, S M
    London School of Hygiene and Tropical Medicine, UK.
    Eczema and educational attainment: A systematic review2017Inngår i: British Journal of Dermatology, ISSN 0007-0963, E-ISSN 1365-2133, Vol. 177, nr 3, s. e47-e49Artikkel, forskningsoversikt (Fagfellevurdert)
    Abstract [en]

    Eczema (syn. atopic dermatitis or atopic eczema) accounts for the largest global burden of disability due to skin disease (1) . Eczema affects up to 20% of children (1) , and is associated with impaired quality of life (QoL) of a similar magnitude to cancer and epilepsy. Yet, although eczema is common in children, little is known about long-term outcomes such as educational attainment (EA) of those affected. This article is protected by copyright. All rights reserved.

  • 17.
    von Kobyletzki, Laura B.
    et al.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper. Lund Univ, Skane Univ Hosp, Dept Dermatol, SE-20502 Malmo, Sweden.
    Berner, A.
    Cty Council Varmland, Primary Care Res Unit, Karlstad, Sweden.
    Carlstedt, F.
    Cty Council Varmland, Primary Care Res Unit, Karlstad Sweden.
    Hasselgren, M.
    Cty Council Varmland, Primary Care Res Unit, Karlstad, Sweden.;Univ Orebro, Sch Med, Orebro, Sweden.
    Bornehag, Carl Gustaf
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper. SP Tech Res Inst Sweden, Boras, Sweden.
    Svensson, A.
    Lund Univ, Skane Univ Hosp, Dept Dermatol, SE-20502 Malmo, Sweden.
    Validation of a Parental Questionnaire to Identify Atopic Dermatitis in a Population-Based Sample of Children up to 2 Years of Age2013Inngår i: Dermatology, ISSN 1018-8665, E-ISSN 1421-9832, Vol. 226, nr 3, s. 222-226Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    Background: Validated eczema questionnaires have been available for schoolchildren only, but the incidence of atopic dermatitis (AD) is highest during infancy. Objective: To validate a parental questionnaire to identify AD in children up to 2 years of age. Methods: Parents of 476 children answered a written questionnaire prior to an examination by a physician. Sensitivity, specificity, predictive values and test-retest reliability of the questionnaire were assessed. Results: A total of 245 (51%) girls and 231 (49%) boys, aged 1-24 months, with and without physician-diagnosed AD participated. Seventy-one children (15%) had physician-diagnosed AD. Validation of the questionnaire by comparisons with physicians' diagnoses showed a sensitivity of 0.87 (95% confidence interval, CI, 0.77-0.94) and a specificity of 0.98 (95% CI, 0.96-0.99). The positive predictive value was 0.90 (95% CI, 0.80-0.96) and the negative predictive value was 0.98 (95% CI, 0.96-0.99). Conclusion: The questionnaire identified AD in children aged 0-2 years with high accuracy.

  • 18.
    von Kobyletzki, Laura B
    et al.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper. Lund Univ, Skne Univ Hosp, Dept Dermatol, Inst Clin Res Malmo, Malmo, Sweden.;Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Bornehag, Carl-Gustaf
    Karlstads universitet, Fakulteten för samhälls- och livsvetenskaper, Avdelningen för hälsa och miljö.
    Breeze, E.
    London Sch Hyg & Trop Med, London WC1, England..
    Larsson, M.
    Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Engman, L. Hagerhed
    SP Tech Res Inst Sweden, Dept Bldg Phys & Indoor Environm, Bors, Sweden..
    Lindstrom, C. Boman
    Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Svensson, A.
    Lund Univ, Skne Univ Hosp, Dept Dermatol, Inst Clin Res Malmo, Malmo, Sweden..
    Remission of eczema in children and influencing factors: a prospective population-based Swedish study2012Inngår i: Experimental dermatology, ISSN 0906-6705, E-ISSN 1600-0625, Vol. 21, nr 3, s. e21-e22Artikkel i tidsskrift (Fagfellevurdert)
  • 19.
    von Kobyletzki, Laura B
    et al.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013). Lund University.
    Bornehag, Carl-Gustaf
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Breeze, Elizabeth
    London School of Hygiene and Tropical Medicine, United Kingdom.
    Larsson, Malin
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Boman Lindström, Cecilia
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Svensson, Ake
    Lund University.
    Factors Associated with Remission of Eczema in Children: A Population-based Follow-up Study2014Inngår i: Acta Dermato-Venereologica, ISSN 0001-5555, E-ISSN 1651-2057, Vol. 90, nr 2, s. 179-184Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    The aim of this study was to analyse factors associated with remission of atopic dermatitis (AD) in childhood. A population-based AD cohort of 894 children aged 1-3 years from a cross-sectional baseline study in 2000 was followed up in 2005. The association between remission, background, health, lifestyle, and environmental variables was estimated with crude and multivariable logistic regression. At follow-up, 52% of the children had remission. Independent factors at baseline predicting remission were: milder eczema (adjusted odds ratio (aOR), 1.43; 95% confidence interval (95% CI) 1.16-1.77); later onset of eczema (aOR 1.40; 95% CI 1.08-1.80); non-flexural eczema (aOR 2.57; 95% CI 1.62-4.09); no food allergy (aOR 1.51; 95% CI 1.11-2.04), and rural living (aOR 1.48; 95% CI 1.07-2.05). Certain aspects of AD and rural living were important for remission, but despite the initial hypotheses to the contrary, the environmental factors examined in this paper were not substantial predictors of remission.

  • 20.
    von Kobyletzki, Laura B.
    et al.
    Lund Univ, Skane Univ Hosp, Dept Dermatol, SE-20502 Malmo, Sweden.
    Bornehag, Carl-Gustaf
    Karlstads universitet, Fakulteten för samhälls- och livsvetenskaper, Avdelningen för hälsa och miljö.
    Hasselgren, Mikael
    School of Medicine, Örebro University.
    Larsson, Malin
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Boman Lindström, Cecilia
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013).
    Svensson, Åke
    und Univ, Skane Univ Hosp, Dept Dermatol, SE-20502 Malmo, Sweden.
    Eczema in early childhood is strongly associated with the development of asthma and rhinitis in a prospective cohort.2012Inngår i: BMC Dermatology, ISSN 1471-5945, E-ISSN 1471-5945, Vol. 12, s. 11-Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    BACKGROUND: This study aimed to estimate the association between eczema in early childhood and the onset of asthma and rhinitis later in life in children.

    METHODS: A total of 3,124 children aged 1-2 years were included in the Dampness in Building and Health (DBH) study in the year 2000, and followed up 5 years later by a parental questionnaire based on an International Study of Asthma and Allergies in Childhood protocol. The association between eczema in early childhood and the incidence of asthma and rhinitis later in life was estimated by univariable and multivariable logistic regression modelling.

    RESULTS: The prevalence of eczema in children aged 1-2 years was 17.6% at baseline. Children with eczema had a 3-fold increased odds of developing asthma (adjusted odds ratio [aOR], 3.07; 95% confidence interval (CI) 1.79-5.27), and a nearly 3-fold increased odds of developing rhinitis (aOR, 2.63; 1.85-3.73) at follow-up compared with children without eczema, adjusted for age, sex, parental allergic disease, parental smoking, length of breastfeeding, site of living, polyvinylchloride flooring material, and concomitant allergic disease. When eczema was divided into subgroups, moderate to severe eczema (aOR, 3.56; 1.62-7.83 and aOR, 3.87; 2.37-6.33, respectively), early onset of eczema (aOR, 3.44; 1.94-6.09 and aOR, 4.05; 2.82-5.81; respectively), and persistence of eczema (aOR, 5.16; 2.62-10.18 and aOR, 4.00; 2.53-6.22, respectively) further increased the odds of developing asthma and rhinitis. Further independent risk factors increasing the odds of developing asthma were a parental history of allergic disease (aOR, 1.83; 1.29-2.60) and a period of breast feeding shorter than 6 months (aOR, 1.57; 1.03-2.39). The incidence of rhinitis was increased for parental history of allergic disease (aOR, 2.00; 1.59-2.51) and polyvinylchloride flooring (aOR, 1.60; 1.02-2.51).

    CONCLUSION: Eczema in infancy is associated with development of asthma and rhinitis during the following 5-year period, and eczema is one of the strongest risk factors. Early identification is valuable for prediction of the atopic march.

  • 21.
    von Kobyletzki, Laura B
    et al.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper. Lund Univ, Skne Univ Hosp, Dept Dermatol, Inst Clin Res Malmo, Malmo, Sweden.;Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Mischo, M.
    Ruhr Univ Bochum, Bochum, Germany..
    Schmidt, D. A.
    N Carolina Agr & Tech State Univ, Dept Phys, Greensboro, NC 27411 USA..
    Bruendermann, E.
    Ruhr Univ Bochum, Bochum, Germany..
    Brockmeyer, N. H.
    Ruhr Univ Bochum, Dept Dermatol, Bochum, Germany..
    Potthoff, A.
    Ruhr Univ Bochum, Dept Dermatol, Bochum, Germany..
    Havenith, M.
    Ruhr Univ Bochum, Bochum, Germany..
    Changes in Antioxidant and Lipid Network in HIV patients compared to young and old patients: Probing Epidermis and Dermis by Raman Spectroscopy2012Inngår i: Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, E-ISSN 1610-0387, Vol. 10, s. 15-15Artikkel i tidsskrift (Fagfellevurdert)
  • 22.
    von Kobyletzki, Laura B
    et al.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper. Lund Univ, Skne Univ Hosp, Dept Dermatol, Inst Clin Res Malmo, Malmo, Sweden.;Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Mischo, Meike
    Schmidt, Diedrich A.
    N Carolina Agr & Tech State Univ, Dept Phys, Greensboro, NC USA..
    Brundermann, Erik
    Brockmeyer, Norbert H.
    Ruhr Univ Bochum, Dept Dermatol, Bochum, Germany..
    Potthoff, Anja
    Ruhr Univ Bochum, Dept Dermatol, Bochum, Germany..
    Havenith, Martina
    Probing epidermis and dermis by Raman spectroscopy: changes in antioxidant and lipid network with age and disease2012Inngår i: International Journal of Cosmetic Science, ISSN 0142-5463, E-ISSN 1468-2494, Vol. 34, nr 4, s. 372-373Artikkel i tidsskrift (Fagfellevurdert)
  • 23.
    von Kobyletzki, Laura B
    et al.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper. Lund Univ, Skne Univ Hosp, Dept Dermatol, Inst Clin Res Malmo, Malmo, Sweden.;Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Svensson, A.
    Lund Univ, Skane Univ Hosp, Dept Dermatol, D-93053 Lund, Sweden..
    Apfelbacher, C.
    Univ Regensburg, Inst Epidemiol & Prevent Med, Regensburg, Germany..
    Schmitt, J.
    Tech Univ Dresden, Ctr Evidence Based Healthcare, Univ Klinikum Carl Gustav Carus, Dresden, Germany..
    Which factors predict remission of infant atopic dermatitis?: A systematic review2014Inngår i: British Journal of Dermatology, ISSN 0007-0963, E-ISSN 1365-2133, Vol. 170, nr 6, s. E52-E53Artikkel i tidsskrift (Annet vitenskapelig)
  • 24.
    von Kobyletzki, Laura B
    et al.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper. Lund Univ, Skne Univ Hosp, Dept Dermatol, Inst Clin Res Malmo, Malmo, Sweden.;Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Thomas, K.
    Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2RD, England..
    Schmitt, J.
    Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Ctr Evidence Based Healthcare, Dresden, Germany..
    Chalmers, J.
    Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2RD, England..
    Deckert, S.
    Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Ctr Evidence Based Healthcare, Dresden, Germany..
    Aoki, V.
    Univ Sao Paulo, Sch Med, Dept Dermatol, Sao Paulo, Brazil..
    Svensson, A.
    Lund Univ, Skane Univ Hosp, Dept Dermatol, S-22100 Lund, Sweden..
    Eczema signs and symptoms: what is important to patients?2014Inngår i: British Journal of Dermatology, ISSN 0007-0963, E-ISSN 1365-2133, Vol. 170, nr 6, s. E11-E11Artikkel i tidsskrift (Annet vitenskapelig)
  • 25.
    von Kobyletzki, Laura B.
    et al.
    Karlstads universitet, Fakulteten för hälsa, natur- och teknikvetenskap (from 2013), Institutionen för hälsovetenskaper (from 2013). Lund Univ, Skane Univ Hosp, Dept Dermatol, SE-20502 Malmo, Sweden.;Karlstad Univ, Dept Publ Hlth Sci, Karlstad, Sweden..
    Thomas, Kim S.
    Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham, England..
    Schmitt, Jochen
    Tech Univ Dresden, Ctr Evidence Based Healthcare, Dresden, Germany..
    Chalmers, Joanne R.
    Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham, England..
    Deckert, Stefanie
    Tech Univ Dresden, Ctr Evidence Based Healthcare, Dresden, Germany..
    Aoki, Valeria
    Univ Sao Paulo, Sch Med, Dept Dermatol, Sao Paulo, Brazil..
    Weisshaar, Elke
    Ruprecht Karls Univ Heidelberg, Dept Clin Social Med Environm & Occupat Dermatol, Heidelberg, Germany..
    Ahubelem Ojo, Jumoke
    Azzon Med, Lagos, Nigeria..
    Svensson, Ake
    Lund Univ, Skane Univ Hosp, Dept Dermatol, SE-20502 Malmo, Sweden..
    What Factors are Important to Patients when Assessing Treatment Response: An International Cross-sectional Survey2017Inngår i: Acta Dermato-Venereologica, ISSN 0001-5555, E-ISSN 1651-2057, Vol. 97, nr 1, s. 86-90Artikkel i tidsskrift (Fagfellevurdert)
    Abstract [en]

    This study investigated the perspective of international patients on individual symptoms of atopic dermatitis (eczema) in determining treatment response. A questionnaire was developed to evaluate the importance of symptoms from the patient's perspective. Patients were asked: "How important are these features in deciding whether or not a treatment is working?", and rated symptoms on a 5-point Likert scale. Patients were approached via Harmonising Outcome Measures for Eczema (HOME) collaborators and self-selected to take part in the on-line survey. Patients from 34 countries (n = 1,111) completed the survey; of these, 423 (38.3%) were parents of children with eczema. Ten items were rated as being "quite important" or "very important" by more than 80% of the respondents: itch, pain/soreness, skin feels hot or inflamed, bleeding, involvement of visible or sensitive body sites, cracks, sleep difficulties, amount of body affected, and weeping/oozing. These results may be of use in determining the face validity of scales from a cross-cultural patients' perspective.

1 - 25 of 25
RefereraExporteraLink til resultatlisten
Permanent link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf